DF/HCC "Pipelines in Oncology" Seminar - Eisai Pharmaceuticals
Senior Scientists from Eisai Pharmaceuticals will present the Eisai Oncology Pipeline in a 12:30 p.m. seminar on Thursday, March 21.
They will also hold One-on-One meetings at MGH in the morning and at DFCI in the afternoon.
The purpose of the pipelines series is to establish strategic alliances and closer working relationships with ongoing drug discovery and development in industry.
Register for the seminar or 1:1 meetings by visiting http://events.dfhcc.harvard.edu/
- Eisai_flyer.pdf26 K